Rochester, MNNCT06058650Now EnrollingIRB Ready

Breast Neoplasm Clinical Trial in Rochester, MN

Access cutting-edge breast neoplasm treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.

Sponsored by Mayo Clinic

Quick Self-Assessment

See if you qualify for this Rochester location

Preparing your pre-screening questions…

Expert Care in Rochester

Access breast neoplasm specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related breast neoplasm treatment provided free

Apply for This Rochester Location

Check if you qualify for this breast neoplasm clinical trial in Rochester, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rochester

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rochester site if eligible
  4. 4Begin participation

About This Breast Neoplasm Study in Rochester

This clinical trial tests how well molecular breast imaging (MBI) works to guide the collection of a breast biopsy in patients with a breast abnormality. Currently, a biopsy is often guided by either ultrasound or mammography in order to ensure that a sample of the correct part of the breast is taken. Sometimes a lesion or part of the lesion cannot be seen on ultrasound or mammography, and, therefore, a biopsy guided with ultrasound or mammography may not be always be accurate. Studies have shown that high resolution MBI may have potential to improve the detection of some breast tumors. This trial uses a new high-resolution MBI system that may help perform a biopsy using MBI.

Sponsor: Mayo Clinic

Who Can Participate

Inclusion Criteria

PART I: Women aged 18 years or older
PART I: If able to become pregnant, negative pregnancy test within 48 hours prior to MBI biopsy procedure
PART I: Individuals who have previously (within the last 3 years) undergo an MBI study and were found to have at least one breast imaging finding on MBI that was subsequently shown (through additional imaging, biopsy or follow-up) to be benign in nature
PART I: Individuals who have agreed to participate in the study and who have signed the study-specific informed consent
PART II: Women aged 18 years or older
PART II: If able to become pregnant, negative pregnancy test within 48 hours prior to MBI biopsy procedure
PART II: Individuals who have previously (within the last 3 years) undergone an MBI study and were found to have at least one breast imaging finding on MBI that was subsequently shown (through additional imaging, biopsy or follow-up) to be benign or probably benign in nature
PART II: Individuals who had recent conventional imaging work-up including either x-ray mammography, ultrasound, MBI, or MRI of the breast and are found to have at least one breast imaging finding for which biopsy is required or recommended, specifically:
Individuals who have a breast abnormality(ies) on imaging with mammography, ultrasound, MBI, or MRI (as per American College of Radiology \[ACR\] Breast Imaging Reporting and Data System \[BIRADS\] 3, or higher) and requiring imaging follow-up or biopsy confirmation
PART II: Individuals who have agreed to participate in the study and who have signed study-specific informed consent

Exclusion Criteria

PART I: Women who are pregnant
PART I: Women who are currently lactating or discontinued breastfeeding \< 2 months prior to the study
PART I: Age less than 18 years
PART I: Women with breast implant(s) in the breast containing the lesion of interest
PART I: Inability to provide informed consent
PART II: Women who are pregnant
PART II: Women who are currently lactating or discontinued breastfeeding \< 2 months prior to the study
PART II: Age less than 18 years
PART II: Women with breast implant(s) in the breast containing the lesion of interest
PART II: Women who have recently (within the last 3 months) undergone biopsy of the breast finding
PART II: Women who are scheduled for a sentinel node procedure using radioactive Tc-99m within 24 hours of MBI-guided biopsy
PART II: Patients with contraindications for core biopsy and other invasive procedures such as blood coagulation disorders, infection, or who are unwilling to discontinue use of anticoagulant medication prior to the procedure
PART II: Inability to provide informed consent
PART II: Women who have had surgery on the study breast(s) within the past 12 months

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rochester?

Yes, this clinical trial (NCT06058650) has an active research site in Rochester, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Breast Neoplasm Treatment Options in Rochester, MN

If you're searching for breast neoplasm treatment options in Rochester, MN, this clinical trial (NCT06058650) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all breast neoplasm clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Rochester, MN

See all breast cancer clinical trials recruiting in Rochester — not just this study.

Browse Breast Cancer Trials in Rochester

Ready to Join in Rochester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rochester, MN